COSI BAIR: COVID-19 Specific vaccine and heterologous Immunity in the Melbourne infant study of BCG for Allergy and Infection Reduction devised measure

Reference and/or access link:

Noé, A., Dang, T., Axelrad, C., Burrell, E., Germano, S., Elia, S., ... & Messina, N. BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists. Frontiers in Immunology14, 1242380.